Introducing the Concept of Small Vulnerable Newborns (SVN) as an Additional Endpoint to Evaluate Birth Outcomes in the Context of RSV Immunization Studies—A Commentary

Documenti analoghi

• Impact of Nirsevimab on RSV and Non‐RSV Severe Respiratory Infections in Hospitalized Infants
  di: María Luz García‐García, et al.
  Pubblicazione: (2025)
• Evaluating the Impact of Different Methods on the Timing and Duration of RSV Epidemics: Analysis of Surveillance Data From the GERi (Global Epidemiology of RSV in Hospitalized and Community Care) Study
  di: Lisa Staadegaard, et al.
  Pubblicazione: (2025)
• Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV
  di: Atsuko Yamamoto, et al.
  Pubblicazione: (2024)
• Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK
  di: Joanna Waldock, et al.
  Pubblicazione: (2024)
• Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]
  di: G. Sever Yildiz, et al.
  Pubblicazione: (2024)